Savaysa OverviewEdoxaban (DU-176b, trade names Savaysa, Lixiana) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. It was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery. It was also approved by the FDA in January 2015 for the prevention of stroke and non–central-nervous-system systemic embolism. Contents 1 Medical uses 2 Contraindicati...
Read more Savaysa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Edoxaban
Recent Savaysa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 15mg, 30mg, 60mg
NDC Database Records for Savaysa: (3 results)Sorted by National Drug Code
- 65597-201 Savaysa 15 mg Oral Tablet, Film Coated by Daiichi Sankyo, Inc.
- 65597-202 Savaysa 30 mg Oral Tablet, Film Coated by Daiichi Sankyo, Inc.
- 65597-203 Savaysa 60 mg Oral Tablet, Film Coated by Daiichi Sankyo, Inc.